Page last updated: 2024-09-03

n-(4-carboxycyclohexylmethyl)maleimide n-hydroxysuccinimide ester and Central Nervous System Lyme Disease

n-(4-carboxycyclohexylmethyl)maleimide n-hydroxysuccinimide ester has been researched along with Central Nervous System Lyme Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, WD; Huang, NL; Huang, XJ; Ma, XL; Schneider, M; Ye, L1

Other Studies

1 other study(ies) available for n-(4-carboxycyclohexylmethyl)maleimide n-hydroxysuccinimide ester and Central Nervous System Lyme Disease

ArticleYear
Establishment of N-succinimidyl 4-(maleimidomethyl) cyclohexanecarboxylate (SMCC) modified biochip enabling concurrent detection of serum infectious antibodies in neuroborreliosis.
    Biosensors & bioelectronics, 2016, Apr-15, Volume: 78

    Topics: Antibodies, Bacterial; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Proteins; Biosensing Techniques; Flagellin; Humans; Immunoglobulin G; Immunoglobulin M; Lipoproteins; Lyme Neuroborreliosis; Maleimides; Protein Array Analysis

2016